FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4367302582> ?p ?o ?g. }

• W4367302582 abstract "<h3>Objective:</h3> To identify if there are chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) patients who do not meet clinical criteria but satisfy electrodiagnostic criteria. Our hypothesis is that these patients do not differ from patients who meet criteria for CIDP and possible CIDP. <h3>Background:</h3> The diagnosis of CIDP remains challenging due to lack of a biomarker or a single diagnostic test. The European Academy of Neurology/Peripheral Nerve Society (EAN/PNS) 2021 revision of the diagnostic criteria for CIDP advocate a stepwise approach to the diagnosis of CIDP which requires clinical criteria including absent or reduced deep tendon reflexes before the application of electrodiagnostic criteria. <h3>Design/Methods:</h3> We applied the 2021 EAN/PNS criteria to our cohort of 39 patients receiving intravenous immunoglobulin (IVIG) for CIDP. We compared clinical and electrodiagnostic criteria between those who fulfilled electrodiagnostic criteria but not clinical criteria and patients with CIDP or possible CIDP <h3>Results:</h3> Of our cohort 39-patients, 21 (53.8%) were classified as CIDP, 6 (15.3%) as possible CIDP and 12 patients didn’t meet criteria. Of the 10 patients who didn’t meet clinical criteria, 6/10 (60%) met electrodiagnostic criteria. These patients did not qualify as CIDP or Possible CIDP due to the presence of reflexes. There were no significant differences in the clinical phenotypes and demographics between these patients and CIDP or possible CIDP patients in our cohort. There was also no significant difference in the electrodiagnostic parameters between these patients and those with CIDP or possible CIDP. However, the patients with preserved reflexes tended to have more frequent conduction velocity slowing (p = 0.08) than patients with CIDP or possible CIDP. <h3>Conclusions:</h3> The presence of reflexes should not exclude the diagnosis of CIDP if the patient meets electrodiagnostic criteria. This could be indicative of a subset of patients with CIDP who have more involvement of the intermediate segments of nerve rather than proximal segments. <b>Disclosure:</b> Dr. Strathdee has nothing to disclose. The institution of Dr. Rodrigues has received research support from Australian Brain Foundation. The institution of Dr. Kapoor has received research support from Bethlehem Griffiths Research Foundation . Dr. Zhang has nothing to disclose. Dr. Faragher has stock in Argo P/L. Dr. Faragher has stock in Australian Foundation P/L. Dr. Faragher has stock in Argo Infrastructure P/L. Bruce Day has nothing to disclose. The institution of Dr. Hutton has received research support from Lundbeck. The institution of Dr. Hutton has received research support from Daewoong Pharmaceuticals . The institution of Dr. Hutton has received research support from Xalud. The institution of Dr. Hutton has received research support from Ipsen. The institution of Dr. Hutton has received research support from Abbvie. The institution of Dr. Hutton has received research support from Cerecin. Dr. Hutton has a non-compensated relationship as a Board Member with Brain Foundation (Vic) that is relevant to AAN interests or activities. Dr. Hutton has a non-compensated relationship as a President-elect with Australian and New Zealand Headache Society that is relevant to AAN interests or activities. Dr. Stark has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Stark has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Stark has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Stark has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Stark has stock in CSL. Dr. Stark has stock in Multiple ASX listed (non-medical) companies. Dr. Stark has received personal compensation in the range of $10,000-$49,999 for serving as a TCMC Committee chair with AMA Victoria." @default.
• W4367302582 created "2023-04-29" @default.
• W4367302582 creator A5010095257 @default.
• W4367302582 creator A5039333995 @default.
• W4367302582 creator A5044566618 @default.
• W4367302582 creator A5044890170 @default.
• W4367302582 creator A5045813542 @default.
• W4367302582 creator A5050593539 @default.
• W4367302582 creator A5052588320 @default.
• W4367302582 creator A5074064703 @default.
• W4367302582 date "2023-04-25" @default.
• W4367302582 modified "2023-10-14" @default.
• W4367302582 title "Presence of deep tendon reflexes may not exclude a diagnosis of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) (P11-8.015)" @default.
• W4367302582 doi "https://doi.org/10.1212/wnl.0000000000204030" @default.
• W4367302582 hasPublicationYear "2023" @default.
• W4367302582 type Work @default.
• W4367302582 citedByCount "0" @default.
• W4367302582 crossrefType "proceedings-article" @default.
• W4367302582 hasAuthorship W4367302582A5010095257 @default.
• W4367302582 hasAuthorship W4367302582A5039333995 @default.
• W4367302582 hasAuthorship W4367302582A5044566618 @default.
• W4367302582 hasAuthorship W4367302582A5044890170 @default.
• W4367302582 hasAuthorship W4367302582A5045813542 @default.
• W4367302582 hasAuthorship W4367302582A5050593539 @default.
• W4367302582 hasAuthorship W4367302582A5052588320 @default.
• W4367302582 hasAuthorship W4367302582A5074064703 @default.
• W4367302582 hasConcept C126322002 @default.
• W4367302582 hasConcept C159654299 @default.
• W4367302582 hasConcept C167135981 @default.
• W4367302582 hasConcept C187212893 @default.
• W4367302582 hasConcept C203014093 @default.
• W4367302582 hasConcept C2777052087 @default.
• W4367302582 hasConcept C2778691916 @default.
• W4367302582 hasConcept C2779867792 @default.
• W4367302582 hasConcept C71924100 @default.
• W4367302582 hasConcept C72563966 @default.
• W4367302582 hasConceptScore W4367302582C126322002 @default.
• W4367302582 hasConceptScore W4367302582C159654299 @default.
• W4367302582 hasConceptScore W4367302582C167135981 @default.
• W4367302582 hasConceptScore W4367302582C187212893 @default.
• W4367302582 hasConceptScore W4367302582C203014093 @default.
• W4367302582 hasConceptScore W4367302582C2777052087 @default.
• W4367302582 hasConceptScore W4367302582C2778691916 @default.
• W4367302582 hasConceptScore W4367302582C2779867792 @default.
• W4367302582 hasConceptScore W4367302582C71924100 @default.
• W4367302582 hasConceptScore W4367302582C72563966 @default.
• W4367302582 hasLocation W43673025821 @default.
• W4367302582 hasOpenAccess W4367302582 @default.
• W4367302582 hasPrimaryLocation W43673025821 @default.
• W4367302582 hasRelatedWork W1842215991 @default.
• W4367302582 hasRelatedWork W1964907319 @default.
• W4367302582 hasRelatedWork W1977398783 @default.
• W4367302582 hasRelatedWork W2094884909 @default.
• W4367302582 hasRelatedWork W2261950073 @default.
• W4367302582 hasRelatedWork W2270897533 @default.
• W4367302582 hasRelatedWork W2411027777 @default.
• W4367302582 hasRelatedWork W2603773853 @default.
• W4367302582 hasRelatedWork W2915739508 @default.
• W4367302582 hasRelatedWork W3201980968 @default.
• W4367302582 isParatext "false" @default.
• W4367302582 isRetracted "false" @default.
• W4367302582 workType "article" @default.